ISPE UK 2025 Industry Awards

12 June, 2025
annoucnemtn

 

The ISPE UK Affiliate is excited to introduce three new awards that will spotlight excellence in our industry:

✅ Pharmaceutical Sustainability Project of the Year Award
✅ Pharmaceutical Collaboration of the Year Award
✅ Pharmaceutical Manufacturing Innovation Award

We’re calling on professionals across the UK pharmaceutical and life sciences sector to nominate outstanding peers, teams, or even themselves for these honours.

Award winners will be celebrated during our flagship 2025 ISPE UK Affiliate Annual Awards Dinner on 13th November in Manchester – a prime platform for national recognition and knowledge exchange.

Award Benefits

  • Recognition as a leader at the 2025 ISPE Annual Awards Dinner.
  • Media exposure and promotion through industry publications and online platforms.
  • Opportunity to present the winning project and insights at relevant industry forums.


Ready to recognise brilliance?

SPOYA

 

PHARMACEUTICAL SUSTAINABILITY PROJECT OF THE YEAR

The "Pharmaceutical Sustainability Project of the Year" award recognises exceptional initiatives within the pharmaceutical industry that demonstrate innovation and commitment to sustainability. This award honours projects that effectively minimise environmental impact, promote sustainable practices, and contribute to the overall well-being of communities and ecosystems.

Eligibility

  • Open to UK pharmaceutical companies, research institutions, and organisations involved in any project within the pharmaceutical sector.
  • The project must have demonstrable results or impacts initiated or achieved between 01 October 2024 – 30 September 2025.
  • Evidence of sustainability integration into the project's planning, execution, and outcomes.

Criteria for Evaluation

  1. Innovation and Creativity
  • Demonstrates unique approaches and cutting-edge methods that differentiate the project from conventional practices.
  • Incorporates innovative solutions to address sustainability challenges in the pharmaceutical sector.
  1. Environmental Impact and Social Responsibility
  • Significantly reduces waste, emissions, or resource consumption.
  • Implements practices that enhance environmental preservation and conservation efforts.
  • Positively impacts surrounding communities and contributes to better health outcomes.
  • Promotes social equity and ethical considerations in its execution.
  1. Scalability and Replicability
  • Offers potential for scaling or adaptation across other regions or contexts.
  • Demonstrates a model that can be replicated to drive broader industry change.
  1. Collaboration and Stakeholder Engagement
  • Involves collaboration with partners, stakeholders, or communities.
  • Fosters strong engagement and communication with all involved parties.

How to Apply

Click on the button below to download the application form. Further details and guidance on the application process are also detailed in the application form

Apply Now!

 

CPOYA

 

PHARMACEUTICAL COLLABORATION OF THE YEAR

Overview

The "Pharmaceutical Collaboration of the Year" award celebrates outstanding partnerships within the pharmaceutical industry that exemplify the power of collaboration in driving innovation, improving patient outcomes, and advancing scientific and engineering knowledge. This award acknowledges joint efforts that have effectively combined resources, expertise, and vision to achieve significant milestones.

Eligibility

  • Open to collaborations between UK pharmaceutical companies, research institutions, academia, healthcare providers, and other organisations, such as design houses, consultancies and equipment manufacturers.
  • The collaboration must have measurable achievements or impacts within 01 October 2024 – 30 September 2025.
  • The project should demonstrate collaborative synergy and shared goals among partners.

Criteria for Evaluation

  1. Innovation and Scientific Advancement
  • Fosters ground-breaking technological advancements.
  • Leverages collaborative efforts to solve complex health challenges.
  1. Uniqueness
  • What is special about this collaboration, not seen on other projects?
  • What is uniquely achieved by collaboration not otherwise achievable or viable?
  1. Impact on Patient Outcomes
  • Evidently improves the industry in improving the health and quality of life for patients.
  • Contributes to the development of new treatments, therapies, or healthcare models.
  1. Effective Synergy and Teamwork
  • Demonstrates seamless integration of partner efforts, resources, and strengths, including novel ways of collaboration.
  • Engages diverse partners and stakeholders to enhance project delivery.
  • Illustrates effective communication, coordination, and shared decision-making.
  1. Scalability and Future Potential
  • Possesses potential for expanding the collaboration’s scope or applicability.
  • Offers a model for similar collaborative efforts in the industry.

How to Apply

Click on the button below to download the application form. Further details and guidance on the application process are also detailed in the application form

Apply Now!

 

MIOYA

 

PHARMACEUTICAL MANUFACTURING INNOVATION OF THE YEAR

Overview

The "Manufacturing Innovation" award recognises excellence in the implementation of cutting-edge technologies or practices that enhance pharmaceutical manufacturing processes. This award applauds projects that significantly improve efficiency, quality, and sustainability within the manufacturing domain through technological innovation and lean practice.

Eligibility

  • Open to pharmaceutical companies, technology providers, and organisations involved in or supporting the UK pharmaceutical industry.
  • The technology application must demonstrate tangible benefits achieved within 01 October 2024 – 30 September 2025.
  • Projects should illustrate the integration of innovative technology into manufacturing operations.

Criteria for Evaluation

  1. Innovation and Technological Advancement
  • Demonstrates the use of novel or advanced technology in manufacturing processes.
  • Pioneers new methods or applications that push industry boundaries.
  1. Impact on Manufacturing Efficiency
  • Significantly enhances productivity, reduces costs, or optimises resource usage.
  • Improves manufacturing processes, output quality, or turnaround times.
  1. Quality and Compliance
  • Advances product quality and consistency while adhering to regulatory standards.
  • Implements technology that enhances monitoring, control, and compliance.
  1. Replicability
  • Offers potential for replicability across different sites or product lines.
  • Provides a model for other manufacturers to adopt similar innovations.

How to Apply

Click on the button below to download the application form. Further details and guidance on the application process are also detailed in the application form

Apply Now!